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BCL2-associated athanogene cochaperone 6 (Bag6) plays a central
role in cellular homeostasis in a diverse array of processes and is
part of the heterotrimeric Bag6 complex, which also includes
ubiquitin-like 4A (Ubl4A) and transmembrane domain recognition
complex 35 (TRC35). This complex recently has been shown to be
important in the TRC pathway, the mislocalized protein degrada-
tion pathway, and the endoplasmic reticulum-associated degrada-
tion pathway. Here we define the architecture of the Bag6
complex, demonstrating that both TRC35 and Ubl4A have distinct
C-terminal binding sites on Bag6 defining a minimal Bag6 complex.
A crystal structure of the Bag6–Ubl4A dimer demonstrates that
Bag6–BAG is not a canonical BAG domain, and this finding is sub-
stantiated biochemically. Remarkably, the minimal Bag6 complex
defined here facilitates tail-anchored substrate transfer from small
glutamine-rich tetratricopeptide repeat-containing protein α to
TRC40. These findings provide structural insight into the complex
network of proteins coordinated by Bag6.
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The well-studied BCL2-associated athanogene cochaperone 6(Bag6, also known as “BAT3” or “Scythe”) plays a central
role in membrane protein quality control, with additional links to
apoptosis, gene regulation, and immunoregulation (for reviews,
see refs. 1–3). Recent studies demonstrated that Bag6 forms
a heterotrimeric Bag6 complex with ubiquitin-like 4A (Ubl4A)
and transmembrane domain recognition complex 35 (TRC35) (4,
5) that mediates the fates of membrane proteins in tail-anchor
(TA) protein targeting (6), mislocalized protein degradation (7),
and endoplasmic reticulum (ER)-associated protein degradation
(4). The many roles of the Bag6 complex likely are centered on its
ability to bind exposed hydrophobic regions of proteins, such as
transmembrane domains. In the cytoplasm, the Bag6 complex
directs substrates either to targeting factors for the ERmembrane
(for TA proteins) or to ubiquitylation and subsequent proteaso-
mal degradation.
Bag6 initially was described as part of the gene cluster that
included the human MHC class III on chromosome 6, resulting
in its first name, “HLA-B–associated transcript 3” (BAT3) (8).
The genomic localization suggested a role in immune response,
and this suggestion has been supported by evidence of its roles in
Th1 cell survival (9), natural killer cell cytotoxicity (10), and
MHC class II molecule presentation (11, 12). The initial Bag6
link to apoptosis was based on its interaction with Reaper, an
apoptosis-inducing Drosophila protein (13). Bag6 was not iden-
tified in initial searches for functional homologs of Bag1 (14),
which identified four additional proteins (Bag2–5) (15). The
designation of Bag6 as a Bag family member came later from
limited sequence homology to the defined BAG domain and an
apparent heat shock cognate 70 (Hsc70)-regulating activity
found in other Bag family members (16).
In mammals, Bag6 has been shown to be critical in the tar-
geting of TA proteins to the ER by the transmembrane recog-
nition complex (TRC) pathway (5), a process best understood in
the equivalent fungal guided entry of tail-anchored proteins
(GET) pathway (17, 18). Although Bag6 is missing in fungi, the
analogous yeast complex contains two proteins, Get4 and Get5/
Mdy2, which are homologs of the mammalian proteins TRC35
and Ubl4A, respectively. In yeast, these two proteins form
a heterotetramer that regulates the handoff of the TA protein
from the cochaperone small, glutamine-rich, tetratricopeptide
repeat protein 2 (Sgt2) [small glutamine-rich tetratricopeptide
repeat-containing protein (SGTA) in mammals] to the delivery
factor Get3 (TRC40 in mammals) (19–22). It is expected that the
mammalian homologs, along with Bag6, play a similar role (23–
27). Bag6 also interacts with other proteins such as apoptosis-
inducing factor, glycoprotein 78 (gp78), regulatory particle 5, and
brother of regulator of imprinted sites (BORIS) (16, 27–32) and
can homo-oligomerize, increasing the level of complexity (30).
These findings build a picture of Bag6 as a central hub for a diverse
physiological network of proteins.
A variety of diseases, ranging from cancer to autoimmune
disorders and diabetes, are linked to Bag6 (33-37). Despite this
demonstrated importance, structural characterization of the Bag6
complex is lacking. The longest and most common isoform of the
Bag6 gene encodes an 1,132-aa protein (38) with an N-terminal
ubiquitin-like (UBL) domain that has been characterized struc-
turally (PDB ID codes 4EEW, 4DWF, and 1WX9), a large pro-
line-rich central domain that is predicted to be unstructured, and
a C-terminal predicted BAG domain (Bag6-BAG). In this study,
we map the TRC35- and Ubl4A-binding regions to the C termi-
nus of Bag6. Based on these results, the structure of the complex
between the heterodimerization domains of Bag6 and Ubl4A was
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solved, revealing unexpected structural homology to Get5 and
showing that the Bag6-BAG is a “mock” BAG domain, as was
demonstrated further biochemically. Finally, a defined minimal
Bag6 complex facilitates the transfer of a TA substrate from
SGTA to TRC40 in vitro.
Results
TRC35 Binds the Bag6 Nuclear Localization Sequence, Whereas Ubl4A
Binds the BAG Domain.To define the molecular architecture of the
heterotrimeric Bag6 complex (Bag6, Ubl4A, and TRC35), a se-
ries of yeast two-hybrid assays were performed. Bag6 was divided
into five fragments: A (amino acids 1–225), B (amino acids 226–
399), C (amino acids 400–659), D (amino acids 660–950), and E
(amino acids 951–1,126), with the activating domain attached at
the N terminus (Fig. 1A); TRC35 or Ubl4A contained N-ter-
minal DNA-binding domains. TRC35 and Ubl4A both showed
a positive interaction with the C-terminal Bag6E fragment that
contains the nuclear localization sequence (NLS) and the BAG
domain (Fig. 1B). To refine the interfaces, Bag6E was divided
further into an N-terminal domain, an NLS domain, and the
putative BAG domain (EN, ENLS, and EBAG respectively) (Fig.
1A). TRC35 showed an interaction with ENLS (Fig. 1B) con-
firming the in vivo result that TRC35 masks the Bag6-NLS,
preventing nuclear targeting (4). Ubl4A showed an interaction
with EBAG (Fig. 1B), a surprising result because none of the five
previously characterized BAG domains was known to form sta-
ble interactions with other proteins.
According to sequence alignment, Ubl4A lacks the Get5 N-
terminal domain, and TRC35 lacks the β-loop in Get4 (Fig. 2A),
both of which are involved in the Get4 interface with Get5 (19).
This difference suggests there are different interactions in the
Bag6 complex. One possibility is that the region around the Bag6
NLS acts structurally like the Get5 N domain by binding the
C domain of TRC35. To confirm this hypothesis, a two-hybrid
experiment was performed with TRC35 split into either an
N domain (TRC35-N, residues 1–157) or a C domain (TRC35-C,
residues 158–327), as had been done previously for Get4 (Fig.
2A) (39). As predicted, Bag6E showed a clear interaction with
TRC35-C and no interaction with TRC35-N (Fig. 2B). Surpris-
ingly, the smaller Bag6ENLS did not interact with TRC35-C (Fig.
2B) despite the previously seen interaction with full-length
TRC35 (Fig. 1B). This interaction was restored with the longer
Bag6EN,NLS, suggesting that additional contacts are required to
form a stable interaction. This extended region defines a minimal
complex with TRC35 bound to the C terminus of Bag6 in close
proximity to Ubl4A, similar to the architecture found in the yeast
Get4-5 complex.
The next goal was to purify the heterotrimeric complex. Both
full-length Bag6 and TRC35 were recalcitrant to recombinant
expression in Escherichia coli. For TRC35, expression required
removal of residues at the N and C termini that are not con-
served, TRC35(23–305). This truncated TRC35 behaved like
wild-type by yeast two-hybrid assay with Bag6E (Fig. S1A).
Additionally, based on all the interaction results, a minimal
Bag6 fragment (Bag6min, residues 1,001–1,126) was constructed
that removed the 50 N-terminal residues of Bag6E. The coex-
pression of Bag6min, TRC35(23–305), and Ubl4A resulted in
a stable complex that could be purified (Fig. S1B). Although
a TRC35–Bag6E complex could not be obtained, the hetero-
dimeric Ubl4A–Bag6E was well expressed and could be purified
to homogeneity.
The Crystal Structure of Bag6-BAG/Ubl4A-C. For structural charac-
terization, multiple variants of the Bag6min complex were pur-
sued for crystallization. One consisting of the Ubl4A C-terminal
dimerization domain (Ubl4A-C) and the Bag6 BAG domain
(Bag6-BAG, residues 1,054–1,107) resulted in well-formed
crystals. A complete 2.1-Å native dataset was collected in the
space group P21 and was phased using an iodide derivative. The
final refinement resulted in an Rfree of 28.0% (Table S1). Both
domains are primarily helical (Fig. 3A) with an extensive dimer
interface dominated by conserved hydrophobic residues that
results in 2,485 Å2 of buried surface (Fig. 3A). Bag6-BAG con-
tains three helices in an extended conformation making few
intramolecular contacts. Ubl4A-C contains three helices with the
first two forming an interface and the short third helix wrapping
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Fig. 1. Bag6 has distinct binding sites for TRC35 and Ubl4A at its C terminus.
(A) Scheme of the five different Bag6 fragments and of the subfragments of
Bag6E, which is divided further into the N terminus (EN), the NLS (ENLS), and
a fragment containing only the putative BAG domain (EBAG). (B, Left) Yeast
two-hybrid assay between Bag6 fragments and either TRC35 or Ubl4A. The A
fragment contains the UBL domain, and the E fragment contains the NLS
and putative BAG domain. (Right) Yeast two-hybrid assay of TRC35 or Ubl4A
and the Bag6 E fragments.
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Fig. 2. Defining the interaction between Bag6 and TRC35 by yeast two-
hybrid assay. (A, Upper) Diagram of the Get4/Get5-N complex (PDB ID
code 3LKU). Get4 is shown in gray and red, and Get5 is shown in green.
(Lower) A top-view schematic representation of the architecture. The two
β-strands in Get4 that are missing in TRC35 are outlined in blue. Ubl4A
does not contain a Get5-N equivalent. (B) Bag6E fragments containing the
activating domain were combined with full-length TRC35 (FL), TRC35-N
(residues 1–157), or TRC35-C (residues 158–327) conjugated to the binding
domain. TRC35-N and TRC35-C were defined by sequence alignment
with Get4.
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around Bag6-BAG (Fig. 3A). All the conserved hydrophobic
residues of Bag6-BAG participate in dimerization (Fig. 3B).
Although fungal Get5 forms a stable homodimer mediated by
Get5-C, Ubl4A alone is primarily a monomer (20). Because
Ubl4A forms a heterodimer with Bag6, one might expect a novel
fold for Ubl4A-C; instead, the Ubl4A-C heterodimerization
domain has a structure identical to the Get5-C homodimeriza-
tion domain, an rmsd of 0.94 Å for equivalent backbone residues
(Fig. 4 A and B). The hydrophobic residues that form the core in
Get5 homodimerization—W179, I182, L186, F190, V200, L204,
W208—are conserved in Ubl4A—W96, I99, L103, F107, V115,
L119, Y123 (Fig. 4 B and C).
Bag6-BAG Is a Mock BAG Domain. Previous results had demon-
strated that the ability of Bag6 to inhibit Hsc70 refolding of
substrates in vitro is dependent on the presence of the 81
C-terminal residues (Bag6-C81), which include the BAG domain
(16). This result was suggested to be equivalent to results for the
Bag1 BAG domain, a demonstrated nucleotide-exchange factor
for Hsc70 (40). If true, Bag6-BAG should inhibit Hsc70-mediated
protein folding (41). To assay this possibility, denatured β-galac-
tosidase was folded in vitro in the presence of human Hsc70 and
human DnaJ protein I (Hdj1), as done previously (16, 42).
Folding was measured as the percent of β-galactosidase activity
recovered after the folding reaction was quenched. With both
Hsc70 and Hdj1 present, a maximal refolded activity of ∼35%
was recovered after 180 min (Fig. 5A, brown line), but no
refolding was seen when only BSA was added (Fig. 5A, black
line). The addition of human Bag1-BAG to Hsc70 and Hdj1
completely inhibited the ability of Hsc70 to fold the protein (Fig.
5A, purple line), as was consistent with previous results (41).
Conversely, the addition of Bag6-BAG had no effect on refolding
by Hsc70 (Fig. 5A, solid orange line).
The inconsistency with previous results might be explained by
copurification of endogenous Bag6-binding partners. In the earlier
study, affinity-tagged full-length human Bag6 and Bag6ΔC81 were
expressed and purified from insect cells over a single-affinity resin
(16). Because the proteins are highly conserved, it is reasonable to
assume that endogenous insect Ubl4A could be a contaminant
and might have contributed to the inhibition. The introduction of
the Bag6-BAG/Ubl4A complex to the reaction had no effect on
folding (Fig. 5A, blue line). SGTA, a cochaperone, recently has
been shown to form a specific complex with Ubl4A (24) and also
may have been present in the endogenously purified sample.
SGTA had no significant effect on activity (Fig. S2) with or
without the other factors (Fig. 5A, dashed lines). Bag6-C81, which
was required for inhibition in the previous study, is slightly larger
than the BAG domain defined here (Fig. 1A). However, using this
larger fragment also had no effect on folding (Fig. S2). Together,
these results suggest that, although the 81 C-terminal residues of
Bag6 are required for its chaperoning activity, Bag6-C81 does not
act as a bona fide BAG domain to cooperate with Hsc70.
This conclusion was supported further by binding assays. A
6x-histidine (6xHis)-tagged Hsc70-nucleotide binding domain
(NBD), the expected binding site for Bag proteins, was incubated
with purified Bag6-C81, Bag6-BAG, Bag6-BAG/Ubl4A, or
Bag1-BAG. After incubation, Hsc70-NBD was captured on
nickel-nitrilotriacetic acid-agarose (Ni-NTA) beads along with
A
B
Fig. 3. The crystal structure of the Bag6-BAG/Ubl4A-C heterodimer. (A) The
overall structure of the Bag6-BAG/Ubl4A-C heterodimer in ribbon representation
with Bag6-BAG shown in cyan and Ubl4A-C shown in magenta. Hydrophobic
residues in Bag6 involved in packing are highlighted as orange sticks. (B) Se-
quence alignment of Bag6-BAG. D.mel, Drosophila melanogaster; D.rer, Danio
rerio; H.sap, Homo sapiens; S.kow, Saccoglossus kowalevskii; T.cas, Tribolium
castaneum; and X.tro, Xenopus tropicalis. The secondary structure based on the
structure is highlighted above the text. The conserved hydrophobic and aromatic
residues involved in the hydrophobic packing interactions between Bag6-BAG
and Ubl4A-C are highlighted in orange. The extended Drosophila melanogaster
sequence is a predicted protein sequence based on theoretical translation and
may not reflect a physiological isoform.
A B
C
Fig. 4. Ubl4A-C and Get5-C are structurally homologous. (A) A monomer of Get5-C (green) (PDB ID code 3VEJ) and Ubl4A-C (pink) are overlaid. Bag6-BAG is
included in cyan. (Inset) the Get5-C homodimer. (B) Ubl4A-C and Get5-C are juxtaposed with conserved residues involved in dimerization highlighted as
orange sticks. (C) Sequence alignment of Ubl4A-C homologs (A.fum, Aspergillus fumigatus; D.rer, Danio rerio; H.sap, Homo sapiens; S.cer, Saccharomyces
cerevisiae; X.tro, Xenopus tropicalis) and the Drosophila apoptosis-inducing protein Reaper. The Ubl4A-C and Get5C secondary structures are shown above
(pink) and below (green), respectively. Conserved hydrophobic residues involved in dimerization are highlighted in orange.
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any associated protein. As expected, Hsc70-NBD was able to
capture the Bag1-BAG domain (Fig. S3C). On the other hand,
Hsc70-NBD was unable to capture any of the Bag6 C-terminal
fragments at levels above background. Thus, one would conclude
that Bag6-BAG is unlike canonical BAG domains in its ability to
interact with Hsc70 in vitro.
Although the evidence makes it clear that the Bag6 BAG do-
main does not interact with Hsc70 in isolation, the role of other
unknown factors could not be ruled out. For instance, SGTA
could mediate the interaction between Bag6-BAG and Hsp70,
because it binds Hsp70 via its tetratricopeptide repeat domain
and Ubl4A via its N terminus (25). To address the possibility of
accessory factors, tagged variants of BAG domains were in-
cubated with 293T whole-cell lysate (Fig. 5B). The positive con-
trol Bag1-BAG again was able to capture a significant amount of
Hsc70. A complex with Bag6-BAG and either the crystallized
fragment or full-length Ubl4A was unable to capture Hsc70.
These results are in contrast to previous experimental results in
which Bag6 inhibition of Hsc70 was dependent on the presence of
the BAG domain (16), but could not rule out the possibility of
binding Hsc70 in the context of the full-length Bag6. To test this
possibility, 293T cells were transfected with either FLAG-Bag6 or
FLAG-Bag6ΔC81 and were captured with anti-FLAG resin. Pro-
teins bound to the beads were blotted with both Bag6 and Hsp70
antibodies (green and red, respectively, in Fig. 5C). Full-length
Bag6 captured a small amount of Hsc70 over background; however,
the lack of the previously annotated BAG domain (Bag6ΔC81) had
no effect on the amount of captured Hsc70 (Fig. 5C).
Based on the structural characterization, the Bag6-BAG do-
main is shorter (47 residues) than canonical BAG domains (76–
112 residues), and the three helices do not form a BAG-like
three-helix bundle; the few residues equivalent to those involved
in Hsp70 binding of other BAG domains have different ori-
entations (Fig. S3A). Furthermore, circular dichroism of Bag6-
BAG alone indicates no stable secondary structure (Fig. S4).
These results imply that a primary role for Bag6-BAG is to
heterodimerize with Ubl4A, because the two are found in a
stoichiometric complex (5, 7). Combined, these results suggest
that Bag6-BAG, both structurally and biochemically, is not a true
BAG domain but instead is a mock BAG domain.
The Bag6min Complex Is an Independent Module That Facilitates TA
Handoff. The fungal Get4-5 complex binds ATP-bound Get3 and
inhibits its ATPase activity, priming Get3 for TA substrate cap-
ture from Sgt2 (22, 43). One would expect that the trimeric Bag6
complex, which contains the mammalian Get4-5 orthologs, reg-
ulates TRC40 in a similar manner. To test this notion, an in vitro
assay was developed to probe the role of the Bag6min complex in
TA handoff from SGTA to TRC40 using recombinantly purified
proteins (the scheme is shown in Fig. 6A). When coexpressed,
fungal Sgt2 binds GET-dependent TA substrates, and this
complex can be purified (21). Here, histidine-tagged SGTA
(hSGTA) was coexpressed in E. coli with the yeast TA protein
Sec61 beta homolog (Sbh1) that contained an N-terminal maltose-
binding protein (MBP–Sbh1), resulting, after a two-step purifica-
tion, in a stable hSGTA/MBP–Sbh1 complex (Fig. S1B). The final
component, TRC40, was generated as a N-terminal GST tag
(GST-TRC40) (Fig. S1B), as done previously (44, 45). Transfer
was initiated by incubation of hSGTA/MBP–Sbh1 either with
GST-TRC40 alone or with the Bag6min complex (Fig. 6A). The
samples then were precipitated with anti-GST resin, washed in two
steps in the absence of ATP, and probed after Western blotting
with both MBP and GST antibodies. GST-TRC40 was able to
capture some TA from SGTA alone, as seen previously for the
yeast system (Fig. S5 A and C) (21). The additional presence of the
Bag6min complex resulted in an ATP-dependent increase in TA
transfer to TRC40 (Fig. S5A, compare lanes 4 and 6). This increase
in transfer was not a result of a bridged capture of TRC40 pulling
down TA still bound to SGTA. The interaction between SGTA
and Ubl4a is predicted to have very fast off-rates (25), and SGTA
would be removed rapidly during the wash steps. Moreover, cap-
ture of TA by TRC40 was insensitive to increasing salt concen-
tration (Fig. S5 B and D), despite the SGTA/Ubl4a and TRC35/
TRC40 interactions being dominated by electrostatics, the latter
also requiring ATP (22, 25). The Bag6min fragment used in the
study does not contain the Bag6 substrate-binding domain (23);
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Fig. 6. The Bag6min complex facilitates TA transfer from SGTA to TRC40. (A)
The in vitro TA handoff reaction scheme. Recombinantly purified hSGTA-
MBP/Sbh1 complex was incubated with GST-TRC40 and the indicated
recombinant proteins. After incubation on ice for 10 min, GST-TRC40 and
bound substrate were precipitated with anti-GST resin followed by three
washing steps and Western blotting. (B) Mutants affecting SGTA binding to
the Bag6min complex reduce TA transfer to TRC40. GST-TRC40 was captured
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GST-TRC40(K86D) and bound factors were captured and analyzed as in B.
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therefore, the Bag6 complex can promote the handoff of
substrate from SGTA to TRC40 without Bag6 engaging the
substrate directly.
SGTA binds the Bag6 complex via the UBL domain of Ubl4A;
consequently, the Bag6-dependent handoff should require this
interaction (24, 25). To test this hypothesis, the mutants
hSGTA(C38A) and Ubl4A(L43A) were generated; previously,
the equivalent mutations in yeast were shown to disrupt the
homologous interaction (25). As expected, each mutation re-
sulted in a similar loss of substrate handoff relative to wild type
(Fig. 6B, compare lanes 4, 5, and 8, and Fig. S5E). This result
highlights the importance of this interaction for the bridging by
Bag6 during TA transfer.
In yeast, Get4-5 binding regulates Get3 ATPase activity and
TA targeting (43). Therefore, in addition to the bridging role of
the Bag6 complex, it is critical to test if this larger complex plays
a regulatory role in TA targeting. The recently published struc-
ture of yeast Get4 bound to Get3 highlighted a regulatory in-
terface separate from the binding interface (22). When residues
on either side of this regulatory interface were mutated (the
charge swaps K69D on Get3 and D74K on Get4), each mutation
resulted in a loss of ATPase inhibition, reduction of TA insertion
into microsomes, and a loss of fitness in vivo, despite maintaining
a stable complex in vitro (22). Combining the charge swap
mutants restored the Get4 regulatory activity (22). For TRC40,
the corresponding regulatory mutation, K86D, resulted in a re-
duction of the Bag6 complex-facilitated handoff (Fig. 6C, com-
pare lanes 4 and 8, and Fig. S5F). Similarly, the corresponding
regulatory mutation in TRC35, D84K, resulted in a reduction of
facilitated handoff (Fig. 6C, compare lanes 4 and 5, and Fig. S5F).
Excitingly, as seen for the yeast system (22), the combination of
these two charge swap mutants resulted in a rescue of the facil-
itated handoff (Fig. 6C, lane 9, and Fig. S5F). These results show
that this minimal Bag6 complex acts as an independent TA-tar-
geting module and performs a regulatory role similar to that of
the fungal Get4-5 complex despite the different architectures.
Discussion
The Bag6 complex has been implicated in various cellular path-
ways, necessitating a description of its molecular architecture. In
this study, we examined the trimeric complex and determined the
high-resolution structure of the complex between the hetero-
dimerization domains of Bag6 and Ubl4A. Our structural and
functional characterization revealed that Bag6-BAG is a mock
BAG domain and does not act independently as a BAG protein-
like nucleotide-exchange factor with Hsc70. Instead, it acts as part
of a scaffold, bridging TRC35 and Ubl4A, resulting in a minimal
Bag6 complex that regulates TA handoff.
The demonstrated inability of Bag6-BAG to influence Hsc70
activity is unsurprising if one considers sequence comparisons
with canonical BAG domains. This result brings into question the
reported inhibition of Hsp70-mediated β-galactosidase refolding
by Bag6 (16). A possible explanation is the holdase activity of
Bag6. Bag6 prevents the aggregation of unfolded luciferase by
forming a stable interaction with the exposed hydrophobic core,
preventing Hsp70-mediated refolding (4). Similar Bag6 holdase
activity may have prevented refolding of β-galactosidase. Deletion
of the 81 C-terminal residues may disrupt this holdase through an
unknown mechanism, possibly by occluding the binding site on the
truncated Bag6. The observed Hsp70 inhibition by Bag6, there-
fore, would be a result of sequestration of the unfolded substrate
by Bag6 via its hydrophobic substrate-binding region, which also
could be recognized by Hsp70, resulting in the interaction between
Bag6 and Hsp70.
The first functional annotation of Scythe (the Bag6 Xenopus
homolog) was an ability to bind Reaper, an apoptosis-inducing
protein in Drosophila, thus inhibiting Reaper-induced apoptosis
in Xenopus oocyte extracts (13, 46). Reaper induces apoptosis in
a variety of model systems, including Xenopus oocyte extract
(47), SF-21 insect cells (48), and HeLa human cancer cells (49).
Sequence alignment of the conserved Ubl4A dimerization do-
main and Reaper reveals the conservation of most of the resi-
dues involved in Bag6-BAG/Ubl4A-C dimerization (Fig. 4C),
suggesting that Reaper may disrupt the Bag6/Ubl4A interaction.
This hypothesis would be consistent with Reaper’s binding
the 312-residue C-terminal truncation of Scythe (ScytheC312),
leading to the release of bound factors (13).
Although full-length Scythe and Bag6 inhibit Reaper- and
ricin-triggered apoptosis, excess ScytheC312 (13) or the 131
C-terminal residues (50) of Bag6 can induce apoptotic events.
Because the C-terminal fragment would be consistent with the
Bag6min complex defined here, excess Bag6 C-terminal residues
would disconnect the triaging and holdase/degradation roles of
the complex. The apoptosis connection then could be linked to
TA targeting. Overexpression of Bag6 in HeLa cells exposed to
ricin, an apoptosis inducer, leads to an increase in endogenous
Bcl-2 protein levels, whereas Bag6 knockdown causes down-
regulation of Bcl-2 proteins (50). Several proteins that belong to
the Bcl-2 family, including Bcl-2, MCL1, BAX, and BOK, are
tail-anchored and reside both at the ER and the mitochondria
(51–53). The Bag6 complex then would play an important role in
regulating the localization and turnover of these Bcl-2 proteins,
and this role could be disrupted by Bag6 cleavage.
These results support a model in which the primary role of the
Bag6 C terminus is to bridge TRC35 and Ubl4A. Possible Bag6
dimerization would form a heterohexamer, creating a complex
analogous to the Get4-5 heterotetramer found in yeast and
providing strong mechanistic parallels in TA targeting (Fig. S6).
The N-terminal UBL domain of Bag6 connects the proteasome,
where it interacts with RP non-ATPase 10c (29), with the ER,
where it interacts with gp78 and ubiquitin regulatory X domain-
containing protein 8 (4, 30). Downstream of this connection, the
proline-rich domain has been implicated as the holdase domain
binding to exposed hydrophobic regions and polyubiquitinated
defective ribosomal products (4, 23, 54). Bag6 then acts as
a scaffolding protein, simultaneously binding ubiquitylation
machinery, the proteasome, TA-targeting factors, and proteins
to be triaged. The molecular details of its decision-making pro-
cess and how this process relates to its other functions in apo-
ptosis, gene regulation, and immunoregulation are important
questions for future studies. The results presented in this paper
provide an important foundation for understanding this in-
triguing complex.
Materials and Methods
Detailed descriptions of experiments are provided in SI Materials and
Methods. Briefly, PJ69-4α strain yeast was cotransformed with pGAD and
pGBDU, and protein–protein interaction was assessed by its ability to grow
in SC-Ura-Leu-Ade plates. For crystallization, folding assays, and Hsc70-NBD
pulldowns, human genes were subcloned, expressed in E. coli, and purified
using Ni-affinity, anion exchange, and size-exclusion chromatography. A
truncated Bag6-BAG fragment and Ubl4A-C were crystallized, and the struc-
ture was determined using single wavelength anomalous dispersion. All the
capture assays from whole-cell extract were performed with 293T cell extracts.
FLAG-tagged recombinant full-length Bag6 and Bag6ΔC81 were recombinantly
purified from 293T cells. All proteins used in the TA handoff assay were purified
in E. coli.
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